The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization

Transarterial embolization (TAE) is a personalized technology that offers precise delivery of chemotherapeutic drugs or selective internal radiation therapy for hepatocellular carcinoma (HCC). Beta-emitting radionuclide embolisms for TAE (β-based TARE) are commonly used in the clinic via inducing bi...

Full description

Bibliographic Details
Main Authors: Qianqian Tong, Rou Li, Ruizhi Wang, Changjing Zuo, Danni Li, Guorong Jia, Ye Peng, Xiaohong Li, Jian Yang, Shuai Xue, Qingyun Bai, Xiao Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.1021499/full
_version_ 1798021133394509824
author Qianqian Tong
Qianqian Tong
Rou Li
Ruizhi Wang
Changjing Zuo
Danni Li
Guorong Jia
Ye Peng
Xiaohong Li
Jian Yang
Shuai Xue
Qingyun Bai
Xiao Li
Xiao Li
author_facet Qianqian Tong
Qianqian Tong
Rou Li
Ruizhi Wang
Changjing Zuo
Danni Li
Guorong Jia
Ye Peng
Xiaohong Li
Jian Yang
Shuai Xue
Qingyun Bai
Xiao Li
Xiao Li
author_sort Qianqian Tong
collection DOAJ
description Transarterial embolization (TAE) is a personalized technology that offers precise delivery of chemotherapeutic drugs or selective internal radiation therapy for hepatocellular carcinoma (HCC). Beta-emitting radionuclide embolisms for TAE (β-based TARE) are commonly used in the clinic via inducing biochemical lethality on tumor cells, while alpha-emitting radionuclides-based embolisms for TAE (α-based TARE) are still under study. The feeding artery plays a key role in tumor growth, metastasis, and recurrence. In this research, the auricular central arteries (ACAs) of rabbits were embolized with silk fibroin-based microspheres (SFMs) or SFMs integrated with α (Ra-223) or β (I-131) radionuclides to investigate the influence on vessels. TARE-induced tissue necrosis and the following neovascularization were measured by pathological analysis and 68Ga-DOTA-RGD PET/CT. The results showed that, compared to I-131, Ra-223 enhanced the growth inhibition of human hepatoma cells Huh-7 and induced more DNA double-strand breaks in vascular smooth muscle cells. Unlike β-based TARE, which mainly led to extensive necrosis of surrounding tissues, α-based TARE induced irreversible necrosis of a limited area adjacent to the embolized vessels. RGD PET revealed the inhibition on neovascularization in α-based TARE (SUVmax = 0.053 ± 0.004) when compared with normal group (SUVmax = 0.099 ± 0.036), the SFMs-lipiodol group (SUVmax = 0.240 ± 0.040), and β-based TARE (SUVmax = 0.141 ± 0.026), owing to the avoidance of the embolism-induced neovascularization. In conclusion, α-based TARE provided a promising strategy for HCC treatments via destroying the embolized vessels and inhibiting neovascularization.
first_indexed 2024-04-11T17:09:07Z
format Article
id doaj.art-59c85fca3f3e491c8cc7db60a4b4c3bc
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-04-11T17:09:07Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-59c85fca3f3e491c8cc7db60a4b4c3bc2022-12-22T04:12:57ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852022-10-011010.3389/fbioe.2022.10214991021499The inhibiting effect of alpha-based TARE on embolized vessels and neovascularizationQianqian Tong0Qianqian Tong1Rou Li2Ruizhi Wang3Changjing Zuo4Danni Li5Guorong Jia6Ye Peng7Xiaohong Li8Jian Yang9Shuai Xue10Qingyun Bai11Xiao Li12Xiao Li13School of Chemistry and Bioengineering, Yichun University, Yichun, Jiangxi, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaDepartment of Radiology, Huadong Hospital, Fudan University, Shanghai, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaSchool of Chemistry and Bioengineering, Yichun University, Yichun, Jiangxi, ChinaSchool of Chemistry and Bioengineering, Yichun University, Yichun, Jiangxi, ChinaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, ChinaInstitute of Applied Physics, Chinese Academy of Sciences, Shanghai, ChinaTransarterial embolization (TAE) is a personalized technology that offers precise delivery of chemotherapeutic drugs or selective internal radiation therapy for hepatocellular carcinoma (HCC). Beta-emitting radionuclide embolisms for TAE (β-based TARE) are commonly used in the clinic via inducing biochemical lethality on tumor cells, while alpha-emitting radionuclides-based embolisms for TAE (α-based TARE) are still under study. The feeding artery plays a key role in tumor growth, metastasis, and recurrence. In this research, the auricular central arteries (ACAs) of rabbits were embolized with silk fibroin-based microspheres (SFMs) or SFMs integrated with α (Ra-223) or β (I-131) radionuclides to investigate the influence on vessels. TARE-induced tissue necrosis and the following neovascularization were measured by pathological analysis and 68Ga-DOTA-RGD PET/CT. The results showed that, compared to I-131, Ra-223 enhanced the growth inhibition of human hepatoma cells Huh-7 and induced more DNA double-strand breaks in vascular smooth muscle cells. Unlike β-based TARE, which mainly led to extensive necrosis of surrounding tissues, α-based TARE induced irreversible necrosis of a limited area adjacent to the embolized vessels. RGD PET revealed the inhibition on neovascularization in α-based TARE (SUVmax = 0.053 ± 0.004) when compared with normal group (SUVmax = 0.099 ± 0.036), the SFMs-lipiodol group (SUVmax = 0.240 ± 0.040), and β-based TARE (SUVmax = 0.141 ± 0.026), owing to the avoidance of the embolism-induced neovascularization. In conclusion, α-based TARE provided a promising strategy for HCC treatments via destroying the embolized vessels and inhibiting neovascularization.https://www.frontiersin.org/articles/10.3389/fbioe.2022.1021499/fullhepatocellular carcinomatransarterial radioembolizationα radionuclidesRa-223neovascularizationsilk fibroin
spellingShingle Qianqian Tong
Qianqian Tong
Rou Li
Ruizhi Wang
Changjing Zuo
Danni Li
Guorong Jia
Ye Peng
Xiaohong Li
Jian Yang
Shuai Xue
Qingyun Bai
Xiao Li
Xiao Li
The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
Frontiers in Bioengineering and Biotechnology
hepatocellular carcinoma
transarterial radioembolization
α radionuclides
Ra-223
neovascularization
silk fibroin
title The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
title_full The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
title_fullStr The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
title_full_unstemmed The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
title_short The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
title_sort inhibiting effect of alpha based tare on embolized vessels and neovascularization
topic hepatocellular carcinoma
transarterial radioembolization
α radionuclides
Ra-223
neovascularization
silk fibroin
url https://www.frontiersin.org/articles/10.3389/fbioe.2022.1021499/full
work_keys_str_mv AT qianqiantong theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT qianqiantong theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT rouli theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT ruizhiwang theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT changjingzuo theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT dannili theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT guorongjia theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT yepeng theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT xiaohongli theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT jianyang theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT shuaixue theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT qingyunbai theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT xiaoli theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT xiaoli theinhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT qianqiantong inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT qianqiantong inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT rouli inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT ruizhiwang inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT changjingzuo inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT dannili inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT guorongjia inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT yepeng inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT xiaohongli inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT jianyang inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT shuaixue inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT qingyunbai inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT xiaoli inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization
AT xiaoli inhibitingeffectofalphabasedtareonembolizedvesselsandneovascularization